ABSTRACT
INTRODUCTION: Computed tomography-guided transthoracic fine-needle aspiration (FNA) is a highly sensitive technique for diagnosing malignancy in pulmonary nodules; however, there is great uncertainty regarding the reliability of a benign result. The goal of this study was to characterize the clinical, radiologic, and technical variables associated with a false negative result. METHODS: We performed a consecutive series review of patients who had an initial benign result from an FNA between January 2002 and December 2004. Medical charts were reviewed to identify patients with false negative and true negative results and determine which variables were associated with a missed diagnosis. RESULTS: One hundred and seventy patients underwent an FNA biopsy yielding an initial benign result and had adequate clinical follow-up. Eighteen of these proved to be false negatives and 152 were true negative. Compared with the patients with true negatives, those with false negative results had significantly larger nodules (mean, 27 mm versus 17 mm, p = 0.04), fewer imaging adjustments per needle pass (4.5 versus 6.4, p = 0.01), a higher proportion in whom the needle tip was not documented within the lesion (24% versus 5%, p =0.04), and a higher pneumothorax rate at any point during the procedure (50% versus 22%, p =0.04). When these variables were considered jointly, pneumothorax (p = 0.006), solitary nodule (p = 0.04), and the radiologist who performed the procedure (p = 0.04) were significant predictors of false negative results. CONCLUSIONS: Factors that were associated with false negative results include increased size of lesion, fewer adjustments of the needle, lack of positive cultures, and the occurrence of a pneumothorax. A benign FNA biopsy result should have the procedure reviewed to ensure the results are reliable.
